Our data showed the S100‐A9 concentration was significantly higher in FF‐Exos of PCOS patients compared with normal control, but in supernatant of follicular fluid with no significant difference, which probably suggested that S100‐A9 might exercise its function through exosomes in follicles during PCOS progression. Here, S100A9 is linked to polycystic ovary syndrome.